Security key
63009J107
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 46,821,220
- Total 13F shares
- 5,698,109
- Share change
- -2,736
- Total reported value
- $175,900,273
- Price per share
- $30.87
- Number of holders
- 15
- Value change
- +$46,423
- Number of buys
- 5
- Number of sells
- 5
Report period
Q1 2026
Institutions
15
Top holders
10
NBTX full security history
Previous quarter: Q4 2025
Nanobiotix S.A. SEC filings
Nanobiotix S.A. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 63009J107
Recent filing periods:
Top shareholders of NBTX - Nanobiotix S.A. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC |
13D/G
|
Invus Public Equities, L.P. |
8.9%
|
4,232,829
|
$13,545,053 | $0 | 31 Dec 2023 | |
| BAILLIE GIFFORD & CO |
13D/G
|
— |
4.1%
|
1,919,670
|
$6,142,944 | $0 | 31 Dec 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
12%
|
5,623,816
|
$130,022,626 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
22,923
|
$529,980 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
16,869
|
$390,011 | — | 31 Dec 2025 | |
| Optiver Holding B.V. |
13F
|
Company |
0.03%
|
16,225
|
$375,122 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
9,500
|
$219,641 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
3,600
|
$83,232 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
2,625
|
$61,000 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
2,342
|
$54,141 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,530
|
$35,374 | — | 31 Dec 2025 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
514
|
$11,884 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
500
|
$11,560 | — | 31 Dec 2025 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
229
|
$5,294 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
200
|
$4,624 | — | 31 Dec 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
13
|
$300 | — | 31 Dec 2025 |
Institutional Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q1 2026
As of 31 Mar 2026,
Nanobiotix S.A. - Common Stock (NBTX) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,698,109 shares.
The largest 10 holders included
JOHNSON & JOHNSON, MORGAN STANLEY, Optiver Holding B.V., MARSHALL WACE, LLP, UBS Group AG, BNP PARIBAS FINANCIAL MARKETS, RHUMBLINE ADVISERS, ROYAL BANK OF CANADA, GAMMA Investing LLC, and EverSource Wealth Advisors, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
14
Q1 2026 holders
15
Holder diff
1
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.